- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有257家主力机构披露2025-06-30报告期持股数据，持仓量总计9.74亿股，占流通A股49.71%
- 波段诊断：
-
技术面诊股
诊断结果：7.8技术面打败了89%的股票
技术面评分前10的股票
近期的平均成本为8.80元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为8.80元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"8.80","date":1761554706,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，跑赢行业平均水平。
[{"date":"2025.10.28","stock":"-0.78","trade":"0.24","ind":"-0.22"},{"date":"2025.10.27","stock":"0.79","trade":"0.61","ind":"1.18"},{"date":"2025.10.24","stock":"1.14","trade":"0.39","ind":"0.71"},{"date":"2025.10.23","stock":"0.11","trade":"-1.29","ind":"0.22"},{"date":"2025.10.22","stock":"-0.68","trade":"-0.28","ind":"-0.07"},{"date":"2025.10.21","stock":"1.84","trade":"1.45","ind":"1.36"},{"date":"2025.10.20","stock":"-1.25","trade":"0.44","ind":"0.63"},{"date":"2025.10.17","stock":"-1.46","trade":"-1.55","ind":"-1.95"},{"date":"2025.10.16","stock":"-0.33","trade":"0.01","ind":"0.10"},{"date":"2025.10.15","stock":"4.55","trade":"2.13","ind":"1.22"},{"date":"2025.10.14","stock":"0.35","trade":"-1.02","ind":"-0.62"},{"date":"2025.10.13","stock":"-0.12","trade":"-1.02","ind":"-0.19"},{"date":"2025.10.10","stock":"0.94","trade":"-0.88","ind":"-0.94"},{"date":"2025.10.09","stock":"2.17","trade":"-0.38","ind":"1.32"},{"date":"2025.09.30","stock":"0.24","trade":"0.69","ind":"0.52"},{"date":"2025.09.29","stock":"0.98","trade":"0.77","ind":"0.90"},{"date":"2025.09.26","stock":"-1.09","trade":"-1.00","ind":"-0.65"},{"date":"2025.09.25","stock":"-0.60","trade":"-0.53","ind":"-0.01"},{"date":"2025.09.24","stock":"2.59","trade":"1.74","ind":"0.83"},{"date":"2025.09.23","stock":"-0.61","trade":"-2.59","ind":"-0.18"},{"date":"2025.09.22","stock":"0.37","trade":"-0.03","ind":"0.22"}]
通化东宝,上证指数,生物制品指数
压力支撑
该股压力位为8.73元，支撑位为8.46元。
[{"text":"\u538b\u529b\u4f4d","value":"8.73","date":1761580800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"8.46","date":1761580800,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.1资金面打败了56%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月28日 20:30
| 机构今日流向(万元) | 705.29 | 机构5日流向(万元) | -3798.56 |
| 机构10日流向(万元) | -5620.84 | 机构20日流向(万元) | -14505.68 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加1254.19万股，其中基金净减仓67家，主力净增仓62家，请投资者中长期谨慎为宜。
截止2025-06-30，共257家主力机构（基金252家，一般法人4家，QFII1家），持仓量总计97358.09万股，占流通A股49.71%
其中，基金持仓与2024-12-31相比：
增仓：29家 ，增持 458.14万股
减仓：96家 ，减持 2324.48万股
新出现在主力名单中：117家 ，持有2444.28万股
从主力名单中消失：55家 ，原持有915.52万股
其中，基金持仓与2024-12-31相比：
增仓：29家 ，增持 458.14万股
减仓：96家 ，减持 2324.48万股
新出现在主力名单中：117家 ，持有2444.28万股
从主力名单中消失：55家 ，原持有915.52万股
消息面诊股
诊断结果：5.5消息面打败了61%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 机构评级|华泰证券给予通化东宝“买入”评级
2025-10-28 - 通化东宝：前三季度营收同比增逾50% 胰岛素类似物
2025-10-28 - 重要公告速递：胜宏科技三季度净利环比下降9.88%
2025-10-28 - 通化东宝：10月27日获融资买入4464.51万元
2025-10-28 - 股东追踪|创新药等增持通化东宝
2025-10-28 - 财报速递：通化东宝2025年前三季度净利润12.0
2025-10-28 - 通化东宝：第三季度净利润为9.84亿元，同比增长4
2025-10-27 - 通化东宝国际化再传捷报，今年已获海外4国上市许可
2025-10-27 - 通化东宝发力东南亚市场，出海再迎新进展
2025-10-27 - 通化东宝：10月24日获融资买入2950.98万元
2025-10-25
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2025-10-18 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-24 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-26 |
| 一般消息 | 高管变动 | 调整第十一届董事会审计委员会人员构... | 2025-08-25 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-07-26 |
| 利好 | 业绩预告 | 预计扭亏 | 2025-07-15 |
| 一般消息 | 高管变动 | 个人原因 | 2025-07-04 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-07-04 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-29 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-09 |
| 利好 | 分红转增 | 10派2.5元(含税) | 2025-04-30 |
| 利空 | 业绩预告 | 业绩预亏 | 2025-04-28 |
| 一般消息 | 高管变动 | 因公司组织架构及管理分工安排调整原... | 2025-03-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-03-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-03-11 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-02-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-02-20 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-01-21 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-01-11 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-01-08 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-01-04 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 3条 | 2条 | 1条 |
行业面诊股
诊断结果：6.5行业面打败了81%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2025.10.28","price":"-0.22","value":"0.24"},{"date":"2025.10.27","price":"1.18","value":"0.61"},{"date":"2025.10.24","price":"0.71","value":"0.39"},{"date":"2025.10.23","price":"0.22","value":"-1.29"},{"date":"2025.10.22","price":"-0.07","value":"-0.28"},{"date":"2025.10.21","price":"1.36","value":"1.45"},{"date":"2025.10.20","price":"0.63","value":"0.44"},{"date":"2025.10.17","price":"-1.95","value":"-1.55"},{"date":"2025.10.16","price":"0.10","value":"0.01"},{"date":"2025.10.15","price":"1.22","value":"2.13"},{"date":"2025.10.14","price":"-0.62","value":"-1.02"},{"date":"2025.10.13","price":"-0.19","value":"-1.02"},{"date":"2025.10.10","price":"-0.94","value":"-0.88"},{"date":"2025.10.09","price":"1.32","value":"-0.38"},{"date":"2025.09.30","price":"0.52","value":"0.69"},{"date":"2025.09.29","price":"0.90","value":"0.77"},{"date":"2025.09.26","price":"-0.65","value":"-1.00"},{"date":"2025.09.25","price":"-0.01","value":"-0.53"},{"date":"2025.09.24","price":"0.83","value":"1.74"},{"date":"2025.09.23","price":"-0.18","value":"-2.59"},{"date":"2025.09.22","price":"0.22","value":"-0.03"}]
上证指数,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 我武生物 | 23.82% | 8.05% | 6.3分 |
| 2 | 三生国健 | 14.83% | -2.36% | 6.4分 |
| 3 | 华兰疫苗 | 14.54% | -8.82% | 5.2分 |
| 4 | 万泽股份 | 8.94% | 4.31% | 6.7分 |
| 5 | 通化东宝 | 8.94% | 0.56% | 6.4分 |
| 6 | *ST四环 | 8.26% | 0.00% | 5.1分 |
| 8 | *ST双成 | 4.69% | 3.99% | 5.0分 |
| 10 | 东宝生物 | 4.40% | 1.07% | 5.9分 |
| 12 | 近岸蛋白 | 3.51% | 2.24% | 5.4分 |
| 14 | 华兰生物 | 2.94% | -1.11% | 5.5分 |
| 16 | 辽宁成大 | 2.77% | -0.24% | 5.6分 |
| 18 | 卫光生物 | 1.79% | 1.45% | 5.2分 |
| 20 | 博雅生物 | 1.17% | 1.83% | 5.8分 |
| 22 | 博晖创新 | 0.70% | 0.53% | 5.8分 |
| 24 | 义翘神州 | -0.85% | 3.02% | 5.2分 |
| 26 | 安科生物 | -1.06% | -1.06% | 5.2分 |
| 28 | 康泰生物 | -1.83% | 0.30% | 5.1分 |
| 30 | 天坛生物 | -2.98% | -2.62% | 5.3分 |
| 32 | 甘李药业 | -4.01% | -0.34% | 5.8分 |
| 34 | 沃森生物 | -4.54% | -1.99% | 4.4分 |
| 36 | 康希诺 | -4.95% | 3.32% | 5.6分 |
| 38 | 昊帆生物 | -7.02% | 1.11% | 5.8分 |
| 40 | 百奥泰 | -8.58% | 1.26% | 6.4分 |
| 42 | - | -8.86% | -1.08% | 分 |
| 44 | 特宝生物 | -10.36% | -9.60% | 5.4分 |
| 46 | 君实生物 | -11.05% | -0.92% | 5.4分 |
| 48 | 荣昌生物 | -12.36% | -6.50% | 5.2分 |
| 50 | 康弘药业 | -13.79% | -4.02% | 4.9分 |
| 52 | 诺诚健华 | -15.54% | -2.77% | 4.8分 |
| 54 | 迈威生物 | -22.11% | -7.06% | 4.4分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：很强，居行业前列，两项指标的行业排名分别为 13/72 ， 29/72。
[{"date":"2025-06-30","value":"3.48","vol":"-0.61"},{"date":"2025-03-31","value":"1.70","vol":"0.46"},{"date":"2024-12-31","value":"-0.63","vol":"-0.68"},{"date":"2024-09-30","value":"-0.97","vol":"1.34"},{"date":"2024-06-30","value":"-3.36","vol":"0.49"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
3.48 | 1.70 | -0.63 | -0.97 | -3.36 |
| 行业(%) | -0.61 | 0.46 | -0.68 | 1.34 | 0.49 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"71.45","vol":"68.28"},{"date":"2025-03-31","value":"69.32","vol":"68.43"},{"date":"2024-12-31","value":"73.90","vol":"69.85"},{"date":"2024-09-30","value":"74.47","vol":"70.47"},{"date":"2024-06-30","value":"72.95","vol":"69.69"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
71.45 | 69.32 | 73.90 | 74.47 | 72.95 |
| 行业(%) | 68.28 | 68.43 | 69.85 | 70.47 | 69.69 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，两项指标的行业排名分别为 3/72 ， 2/72。
[{"date":"2025-06-30","value":"85.60","vol":"6902.04"},{"date":"2025-03-31","value":"10.17","vol":"6125.27"},{"date":"2024-12-31","value":"-34.66","vol":"47.35"},{"date":"2024-09-30","value":"-30.78","vol":"175.00"},{"date":"2024-06-30","value":"-45.84","vol":"19.37"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
85.60 | 10.17 | -34.66 | -30.78 | -45.84 |
| 行业(%) | 6902.04 | 6125.27 | 47.35 | 175.00 | 19.37 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"194.48","vol":"5.44"},{"date":"2025-03-31","value":"-49.15","vol":"-8.46"},{"date":"2024-12-31","value":"-103.66","vol":"-9.81"},{"date":"2024-09-30","value":"-108.73","vol":"-52.40"},{"date":"2024-06-30","value":"-147.54","vol":"-9.07"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
194.48 | -49.15 | -103.66 | -108.73 | -147.54 |
| 行业(%) | 5.44 | -8.46 | -9.81 | -52.40 | -9.07 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，两项指标的行业排名分别为 16/72 ， 17/72。
[{"date":"2025-06-30","value":"0.18","vol":"0.14"},{"date":"2025-03-31","value":"0.09","vol":"0.06"},{"date":"2024-12-31","value":"0.27","vol":"0.29"},{"date":"2024-09-30","value":"0.19","vol":"0.22"},{"date":"2024-06-30","value":"0.10","vol":"0.14"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.18 | 0.09 | 0.27 | 0.19 | 0.10 |
| 行业(次) | 0.14 | 0.06 | 0.29 | 0.22 | 0.14 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.53","vol":"0.56"},{"date":"2025-03-31","value":"0.27","vol":"0.26"},{"date":"2024-12-31","value":"0.73","vol":"1.17"},{"date":"2024-09-30","value":"0.50","vol":"0.86"},{"date":"2024-06-30","value":"0.27","vol":"0.55"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.53 | 0.27 | 0.73 | 0.50 | 0.27 |
| 行业(次) | 0.56 | 0.26 | 1.17 | 0.86 | 0.55 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，两项指标的行业排名分别为 10/72 ， 21/72。
[{"date":"2025-06-30","value":"30.25","vol":"-1377.61"},{"date":"2025-03-31","value":"15.19","vol":"-46.99"},{"date":"2024-12-31","value":"41.76","vol":"-11.33"},{"date":"2024-09-30","value":"13.70","vol":"-30.88"},{"date":"2024-06-30","value":"-16.86","vol":"-36179.91"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 30.25 | 15.19 | 41.76 | 13.70 | -16.86 |
| 行业 | -1377.61 | -46.99 | -11.33 | -30.88 | -36179.91 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.97","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.77","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"43.98","vol":"2.73"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.97 | - | 2.77 | - | 43.98 |
| 行业 | 1.59 | 0.00 | 2.01 | 0.00 | 2.73 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 1/72 ， 4/72。
[{"date":"2025-06-30","value":"1.76","vol":"6.64"},{"date":"2025-03-31","value":"2.89","vol":"7.75"},{"date":"2024-12-31","value":"3.02","vol":"6.72"},{"date":"2024-09-30","value":"4.30","vol":"7.02"},{"date":"2024-06-30","value":"4.99","vol":"6.94"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.76 | 2.89 | 3.02 | 4.30 | 4.99 |
| 行业 | 6.64 | 7.75 | 6.72 | 7.02 | 6.94 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.17","vol":"5.30"},{"date":"2025-03-31","value":"1.72","vol":"6.35"},{"date":"2024-12-31","value":"1.80","vol":"5.40"},{"date":"2024-09-30","value":"2.32","vol":"5.66"},{"date":"2024-06-30","value":"2.77","vol":"5.82"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.17 | 1.72 | 1.80 | 2.32 | 2.77 |
| 行业 | 5.30 | 6.35 | 5.40 | 5.66 | 5.82 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 26/72 ， 27/72。
[{"date":"2025-06-30","value":"21.80","vol":"26.73"},{"date":"2025-03-31","value":"13.73","vol":"26.03"},{"date":"2024-12-31","value":"13.26","vol":"25.81"},{"date":"2024-09-30","value":"9.74","vol":"24.44"},{"date":"2024-06-30","value":"7.78","vol":"24.70"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
21.80 | 13.73 | 13.26 | 9.74 | 7.78 |
| 行业(%) | 26.73 | 26.03 | 25.81 | 24.44 | 24.70 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.28","vol":"1.11"},{"date":"2025-03-31","value":"0.16","vol":"0.78"},{"date":"2024-12-31","value":"0.15","vol":"0.87"},{"date":"2024-09-30","value":"0.11","vol":"0.40"},{"date":"2024-06-30","value":"0.08","vol":"0.38"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.28 | 0.16 | 0.15 | 0.11 | 0.08 |
| 行业(%) | 1.11 | 0.78 | 0.87 | 0.40 | 0.38 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 华泰金融(HK) | 2025-09-09 | 买入 | |
| 华泰证券 | 2025-09-09 | 买入 | 买入 |
| 东方证券 | 2025-09-08 | 买入 | |
| 财通证券 | 2025-09-01 | 增持 | |
| 平安证券 | 2025-08-28 | 增持 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"13.08","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"15.82","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"11.68","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.43","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"6.67","blueLineValue":"0.34","type":"YC"}]